CanSino Biologics Inc. (CASBF)
Develops and manufactures vaccines for infectious diseases like COVID-19, Ebola, and meningitis.
$2.60-0.17%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-51.1%
The outlook
CASBF is trading near its 52-week low and below both its 50- and 200-day moving averages, reflecting downward momentum. Analyst coverage appears thin. The stock's trailing P/E of 130 is notably elevated relative to its current price position.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$642.3M
52-wk high
$6.99
52-wk low
$2.60
50-day avg
$3.08
200-day avg
$4.17
Trailing P/E
130.0